<DOC>
	<DOCNO>NCT00802373</DOCNO>
	<brief_summary>Prospective , double-blind , double-dummy , 2-arm , parallel-group , design . Flexible dose regimen solifenacin succinate , fix dose treatment regimen tolterodine . Assessment OAB symptoms patient diary .</brief_summary>
	<brief_title>Solifenacin Succinate Versus Tolterodine 4mg Once Daily</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>At study entry : Patient willing able complete micturition diary correctly Symptoms overactive bladder ( include urinary frequency , urgency urge incontinence ) &gt; = 3 month At randomization : Patient must experience frequency micturition average &gt; = 8 time per 24 hour period 3 day micturition diary period Patient must experience least one follow symptom 3 day micturition diary period : At least 3 episode urinary incontinence , Patients must exhibit urgency least 3 time At study entry : Pregnant woman woman intend become pregnant study woman childbearing potential sexually active practise unreliable method birth control lactate study . Reliable contraceptive method intrauterine device , contraceptive pill combination type , hormonal implant injectable contraceptive Clinically significant outflow obstruction ( discretion investigator ) Significant post void residual volume ( PVR &gt; 200ml ) Significant stress incontinence mixed stress/urge incontinence stress predominant factor determine investigator Patient neurological cause abnormal detrusor activity Evidence symptomatic urinary tract infection , chronic inflammation interstitial cystitis , bladder stone , previous pelvic radiation therapy previous current malignant disease pelvic organ Uncontrolled narrow angle glaucoma , urinary gastric retention medical condition opinion investigator make use anticholinergic contraindicate Non drug treatment include electrostimulation therapy start bladder train program 2 week prior entry , study Use drug intend treat urinary incontinence Diabetic neuropathy Known suspect hypersensitivity solifenacin , tolterodine , anticholinergic lactose Any clinically significant condition , opinion investigator make patient unsuitable trial Participation clinical trial within 30 ( 90 UK ) day prior randomisation Employees Yamanouchi Group , third party associate study , study site At randomization : Patient complete micturition diary accord instruction Total daily urine volume &gt; 3000 ml verify micturition diary</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Overactive Bladder</keyword>
</DOC>